home / stock / bold / bold short
Short Information | Audentes Therapeutics Inc. (NASDAQ:BOLD)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 803,912 |
Total Actual Volume | 7,370,224 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 40,196 |
Average Short Percentage | 12.71% |
Is there a BOLD Short Squeeze or Breakout about to happen?
See the BOLD Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-17-2024 | $10.45 | $11.29 | $11.59 | $10.45 | 123,875 | 22,534 | 18.19% |
04-16-2024 | $10.6 | $10.56 | $10.98 | $10.35 | 116,412 | 16,682 | 14.33% |
04-15-2024 | $11.35 | $10.79 | $11.44 | $10.35 | 111,610 | 20,332 | 18.22% |
04-12-2024 | $11.5 | $11.29 | $11.9008 | $11.2 | 64,060 | 13,126 | 20.49% |
04-11-2024 | $11.5362 | $11.63 | $12.165 | $11.5 | 156,444 | 25,081 | 16.03% |
04-10-2024 | $11.78 | $11.87 | $12.14 | $11.72 | 164,873 | 12,031 | 7.3% |
04-09-2024 | $12.62 | $12 | $13.1 | $11.91 | 264,917 | 37,165 | 14.03% |
04-08-2024 | $13.22 | $12.46 | $13.46 | $12.36 | 290,482 | 80,109 | 27.58% |
04-05-2024 | $13.34 | $13.22 | $13.44 | $13.2 | 241,374 | 37,980 | 15.73% |
04-04-2024 | $13.61 | $13 | $13.7164 | $12.94 | 473,829 | 36,892 | 7.79% |
04-03-2024 | $13.9 | $13.45 | $14.18 | $13.3 | 397,215 | 27,572 | 6.94% |
04-02-2024 | $13.48 | $13.62 | $13.91 | $12.1 | 132,387 | 12,556 | 9.48% |
04-01-2024 | $14.58 | $13.54 | $14.7214 | $13.3 | 596,872 | 78,427 | 13.14% |
03-28-2024 | $14.25 | $14.25 | $15.24 | $14.1 | 1,754,212 | 149,438 | 8.52% |
10-15-2019 | $28.62 | $27.41 | $28.66 | $27.31 | 422,095 | 16,645 | 3.94% |
10-11-2019 | $28.22 | $28.98 | $29.36 | $28.18 | 420,485 | 48,579 | 11.55% |
10-10-2019 | $27.00 | $27.88 | $27.94 | $26.88 | 257,109 | 29,686 | 11.55% |
10-09-2019 | $28.02 | $26.855 | $28.17 | $26.75 | 497,644 | 49,273 | 9.9% |
10-08-2019 | $27.25 | $27.80 | $28.43 | $27.02 | 517,951 | 63,145 | 12.19% |
10-07-2019 | $28.15 | $27.36 | $29.73 | $27.25 | 366,378 | 26,659 | 7.28% |
News, Short Squeeze, Breakout and More Instantly...
Audentes Therapeutics Inc. Company Name:
BOLD Stock Symbol:
NASDAQ Market:
Audentes Therapeutics Inc. Website:
STARMAP ( S tudy T reating A cquired R esistance: M APK A m p lifications) is a first-in-human, 3-part, Phase 1/2 study of BBI-825 as a single agent and in combination with select targeted cancer therapies BBI-825 is a novel, oral, selective ribonucleotide redu...
Findings support the ongoing development of BBI-355, a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1) in Phase 1/2 development, as a differentiated treatment approach for ecDNA-enabled oncogene amplified cancers Third poster presentation to highlight the potential role of ...
Boundless Bio, Inc. (Nasdaq: BOLD), a clinical stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced the pricing of its initial public offering of 6,250,000 ...